Padwal R, McAlister F A, McMurray J J V, Cowie M R, Rich M, Pocock S, Swedberg K, Maggioni A, Gamble G, Ariti C, Earle N, Whalley G, Poppe K K, Doughty R N, Bayes-Genis A
Department of Medicine, University of Alberta, Edmonton, Canada.
BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Int J Obes (Lond). 2014 Aug;38(8):1110-4. doi: 10.1038/ijo.2013.203. Epub 2013 Oct 31.
In heart failure (HF), obesity, defined as body mass index (BMI) ≥30 kg m(-2), is paradoxically associated with higher survival rates compared with normal-weight patients (the 'obesity paradox'). We sought to determine if the obesity paradox differed by HF subtype (reduced ejection fraction (HF-REF) versus preserved ejection fraction (HF-PEF)).
A sub-analysis of the MAGGIC meta-analysis of patient-level data from 14 HF studies was performed. Subjects were divided into five BMI groups: <22.5, 22.5-24.9 (referent), 25-29.9, 30-34.9 and ≥35 kg m(-2). Cox proportional hazards models adjusted for age, sex, aetiology (ischaemic or non-ischaemic), hypertension, diabetes and baseline blood pressure, stratified by study, were used to examine the independent association between BMI and 3-year total mortality. Analyses were conducted for the overall group and within HF-REF and HF-PEF groups.
BMI data were available for 23 967 subjects (mean age, 66.8 years; 32% women; 46% NYHA Class II; 50% Class III) and 5609 (23%) died by 3 years. Obese patients were younger, more likely to receive cardiovascular (CV) drug treatment, and had higher comorbidity burdens. Compared with BMI levels between 22.5 and 24.9 kg m(-2), the adjusted relative hazards for 3-year mortality in subjects with HF-REF were: hazard ratios (HR)=1.31 (95% confidence interval=1.15-1.50) for BMI <22.5, 0.85 (0.76-0.96) for BMI 25.0-29.9, 0.64 (0.55-0.74) for BMI 30.0-34.9 and 0.95 (0.78-1.15) for BMI ≥35. Corresponding adjusted HRs for those with HF-PEF were: 1.12 (95% confidence interval=0.80-1.57) for BMI <22.5, 0.74 (0.56-0.97) for BMI 25.0-29.9, 0.64 (0.46-0.88) for BMI 30.0-34.9 and 0.71 (0.49-1.05) for BMI ≥35.
In patients with chronic HF, the obesity paradox was present in both those with reduced and preserved ventricular systolic function. Mortality in both HF subtypes was U-shaped, with a nadir at 30.0-34.9 kg m(-2).
在心力衰竭(HF)中,肥胖定义为体重指数(BMI)≥30 kg/m²,与正常体重患者相比,其生存率反而更高(“肥胖悖论”)。我们试图确定肥胖悖论在HF亚型(射血分数降低型心力衰竭(HF-REF)与射血分数保留型心力衰竭(HF-PEF))中是否存在差异。
对来自14项HF研究的患者水平数据进行的MAGGIC荟萃分析进行了亚组分析。受试者被分为五个BMI组:<22.5、22.5 - 24.9(参照组)、25 - 29.9、30 - 34.9和≥35 kg/m²。采用经年龄、性别、病因(缺血性或非缺血性)、高血压、糖尿病和基线血压校正的Cox比例风险模型,并按研究分层,以检验BMI与3年总死亡率之间的独立关联。对总体组以及HF-REF组和HF-PEF组分别进行了分析。
23967名受试者(平均年龄66.8岁;32%为女性;46%为纽约心脏协会(NYHA)II级;50%为III级)有BMI数据,其中5609人(23%)在3年内死亡。肥胖患者更年轻,更有可能接受心血管(CV)药物治疗,且合并症负担更高。与BMI在22.5至24.9 kg/m²之间的水平相比,HF-REF受试者3年死亡率的校正相对风险为:BMI <22.5时,风险比(HR)=1.31(95%置信区间=1.15 - 1.50);BMI 25.0 - 29.9时,为0.85(0.76 - 0.96);BMI 30.0 - 34.9时,为0.64(0.55 - 0.74);BMI≥35时,为0.95(0.78 - 1.15)。HF-PEF患者的相应校正HR为:BMI <22.5时,为1.12(95%置信区间=0.80 - 1.57);BMI 25.0 - 29.9时,为0.74(0.56 - (此处原文有误,多了半个括号,应为0.97));BMI 30.0 - 34.9时,为0.64(0.46 - 0.88);BMI≥35时,为0.71(0.49 - 1.05)。
在慢性HF患者中,射血分数降低和保留的患者均存在肥胖悖论。两种HF亚型的死亡率均呈U形,最低点在30.0 - 34.9 kg/m²。